Tech Company Financing Transactions

Synthekine Funding Round

Deerfield Capital, Janus Henderson Investors and Canaan Partners participated in a $107.5 million Series B funding round for Synthekine. The round closed on 6/11/2021.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Proceeds from this financing will support the advancement of the company's proprietary synthekine platform to pre-clinical proof of concept.

Company Information

Company Status
Private & Independent
Mailing Address
1505 O'Brien Dr.
Menlo Park, CA 94025
Email Address
Not Recorded
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific, selective and potent cytokine therapies. Our targeted protein engineering guided by our deep experience in immunology provides transformative immunotherapies for the treatment of cancer and autoimmune disorders.
Synthekine LinkedIn Company Profile
Social Media
Synthekine Company Twitter Account
Company News
Synthekine News
Synthekine on Facebook
Synthekine on YouTube

Management Team

Email & Social
Chief Executive Officer
Debanjan Ray
  Debanjan Ray LinkedIn Profile  Debanjan Ray Twitter Account  Debanjan Ray News  Debanjan Ray on Facebook
Chief Medical Officer
Naiyer Rizvi
  Naiyer Rizvi LinkedIn Profile  Naiyer Rizvi Twitter Account  Naiyer Rizvi News  Naiyer Rizvi on Facebook
Vice President
Richard Murphy
  Richard Murphy LinkedIn Profile  Richard Murphy Twitter Account  Richard Murphy News  Richard Murphy on Facebook
Vice President
Gregory Yedinak
  Gregory Yedinak LinkedIn Profile  Gregory Yedinak Twitter Account  Gregory Yedinak News  Gregory Yedinak on Facebook
VP - Bus. Development
Martin Oft
  Martin Oft LinkedIn Profile  Martin Oft Twitter Account  Martin Oft News  Martin Oft on Facebook
VP - Finance
Robin Knifsend
  Robin Knifsend LinkedIn Profile  Robin Knifsend Twitter Account  Robin Knifsend News  Robin Knifsend on Facebook
VP - Operations
Christine Rocha
  Christine Rocha LinkedIn Profile  Christine Rocha Twitter Account  Christine Rocha News  Christine Rocha on Facebook
VP - R & D
Robert Kastelein
  Robert Kastelein LinkedIn Profile  Robert Kastelein Twitter Account  Robert Kastelein News  Robert Kastelein on Facebook
VP - R & D
Patrick Lupardus
  Patrick Lupardus LinkedIn Profile  Patrick Lupardus Twitter Account  Patrick Lupardus News  Patrick Lupardus on Facebook



Browse more venture capital transactions:

Prev: 6/11/2021: Sentera venture capital transaction
Next: 6/11/2021: ViaCyte venture capital transaction


Share this article


Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary